Scholars Central

EditorialPublished 29 Sep 2025

HPVScreening: Global Advances, Equity, Challenges

Authors: Yuriko Tanaka

Nagoya University Hospital, Japan

Journal of Cancer Diagnosis

Volume 9 · Issue 5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cervical cancer prevention is evolving with HPV primary screening now standard, offering superior protection and sensitivitycompared to cytology. Global elimination efforts, guided by WHO, emphasize vaccination, screening, and treatment, yet face disparities in low-income countries. Innovations like HPV self-sampling increase participation, while \textit{Artificial Intelligence} (AI)promises enhanced diagnostic accuracy. HPV vaccination profoundly alters screening protocols by reducing infections, potentiallyallowing less frequent screening. Triage for HPV-positive results relies on reflex cytology and emerging molecular biomarkers forrisk stratification. Economic evaluations confirm HPV-based screening’s cost-effectiveness, though social determinants still drivescreening disparities. Molecular diagnostics further refine detection, leading to more targeted follow-up.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cancer Diagnosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cancer Diagnosis
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Yuriko Tanaka”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels